We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hepatocyte Growth Factor and Cardiovascular Autonomic Function

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00478127
First Posted: May 24, 2007
Last Update Posted: May 24, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Oita Red Cross Hospital
May 23, 2007
May 24, 2007
May 24, 2007
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Hepatocyte Growth Factor and Cardiovascular Autonomic Function
Not Provided
In this study, we tested the hypothesis that elevated HGF is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.
Not Provided
Observational
Allocation: Random Sample
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Not Provided
Not Provided
Not Provided
Not Provided
Type-2 Diabetes
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Type-2 diabetes

Exclusion Criteria:

  • Type-1 diabetes
Sexes Eligible for Study: All
Child, Adult, Senior
Not Provided
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00478127
AO-272
Not Provided
Not Provided
Not Provided
Not Provided
Oita Red Cross Hospital
Not Provided
Principal Investigator: Futoshi Anan Oita Red Cross Hospital
Oita Red Cross Hospital
May 2007